Venlafaxine Hydrochloride
- Product NDC
- 16714-038
- 11-digit product format
- 167140038
- Labeler code
- 16714
- Product ID
- 16714-038_a4510853-5f1c-45c2-8d31-1b26ece5010b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Venlafaxine Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- NorthStar RxLLC
- Application
- ANDA091272
- Marketing category
- ANDA
- Marketing start
- 2020-10-21
- Marketing end
- 0000-00-00
- Substance
- VENLAFAXINE HYDROCHLORIDE
- Active strength
- 225 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-038-01 | 16714003801 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-038-01) | 2020-10-21 | 0000-00-00 | No | No | Current |
| 16714-038-02 | 16714003802 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-038-02) | 2020-10-21 | 0000-00-00 | No | No | Current |